MDL-102288

N/A

Report date: 2022/08/24 20:00:31

NME

Base Information

Drug NameMDL-102288

Drug Alias NameN/A

ClassificationSmall molecules > Heterocyclic drugs

Mechanisms of ActionGlutamate [NMDA] receptor antagonists

TargetsGlutamate [NMDA] receptor

Therapy Area/IndicationsEpilepsy

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryUnited States

CombinationsNo

Global Highest StatusDiscontinued (Preclinical)

Highest Status in ChinaN/A

Originator CompaniesAventis

China Registration ClassN/A

Active CompaniesN/A

Inactive CompaniesAventis

Active IndicationsN/A

Inactive IndicationsEpilepsy

ATC CodeN/A